NasdaqGS - Nasdaq Real Time Price USD
4D Molecular Therapeutics, Inc. (FDMT)
3.2000
+0.0700
+(2.24%)
At close: 4:00:01 PM EDT
3.1900
-0.01
(-0.31%)
After hours: 4:15:08 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-153,255
-134,585
-75,792
-86,685
-69,134
Investing Cash Flow
-7,231
-302,437
115,717
-17,050
-172,680
Financing Cash Flow
18,418
337,250
156,832
3,085
118,089
End Cash Position
133,526
149,336
249,108
52,351
153,001
Capital Expenditure
-3,707
-3,786
-2,771
-11,536
-9,110
Issuance of Capital Stock
15,693
331,412
148,344
0
114,296
Free Cash Flow
-156,962
-138,371
-78,563
-98,221
-78,244
12/31/2021 - 12/11/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANNX Annexon, Inc.
1.8100
+2.84%
ALGS Aligos Therapeutics, Inc.
5.80
+4.32%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2600
+5.88%
ADVM Adverum Biotechnologies, Inc.
2.0500
-0.49%
RGNX REGENXBIO Inc.
8.64
+3.72%
ALXO ALX Oncology Holdings Inc.
0.4358
-5.14%
WVE Wave Life Sciences Ltd.
6.30
-0.79%
VTYX Ventyx Biosciences, Inc.
1.2100
+2.54%
ACRV Acrivon Therapeutics, Inc.
1.1000
-3.51%
NKTX Nkarta, Inc.
1.7200
-8.02%